FORUM HOME

Co-Chair
Gail H. Cassell, PhD
Vice President, Scientific Affairs and Distinguished Lilly Research Scholar for Infectious Diseases
Eli Lilly and Company

Co-Chair
Jeffrey M. Drazen, MD
Editor-in-Chief
New England Journal of Medicine

Barbara Alving, MD, MACP
Director
National Center for Research Resources

Naomi Aronson, PhD
Executive Director, Technology Evaluation Center
Blue Cross/Blue Shield Association

Hal Barron, MD
Senior Vice President, Development and Chief Medical Officer
Genentech

Leslie Z. Benet, PhD
Professor, Department of Biopharmaceutical Sciences
School of Pharmacy, University of California, San Francisco

Catherine Bonuccelli, MD
Vice President, Development Projects, Symbicort
AstraZeneca Pharmaceuticals

Linda Brady, PhD
Director, Division of Neuroscience and Basic Behavioral Science
National Institute of Mental Health

Robert Califf, MD
Director, Duke Translational Medicine Institute
Professor of Medicine
Vice Chancellor for Clinical and Translational Research
Duke University Medical Center

Scott Campbell, PhD
National Vice President
American Diabetes Association

C. Thomas Caskey, MD
Chief Operating Officer and Director/CEO
University of Texas HSC at Houston

Peter Corr, PhD
Co-Founder and General Partner
Celtic Therapeutics

James H. Doroshow, MD, FACP
Director, Division of Cancer Treatment and Diagnosis
National Cancer Institute

Joseph M. Feczko, MD
SVP, Chief Medical Officer
Pfizer, Inc.

Garret A. FitzGerald, MD
Professor of Medicine
Professor and Chair of Pharmacology
Department of Pharmacology
University of Pennsylvania School of Medicine

Elaine K. Gallin, PhD
Director, Medical Research Programs
Doris Duke Charitable Foundation

Steven K. Galson, MD, MPH
Acting Surgeon General
Office of the Surgeon General
U.S. Department of Health and Human Services

Mikhail Gishizky, PhD
Chief Scientific Officer
Entelos, Inc.

Stephen Groft, PharmD
Director, Office of Rare Disease Research
National Institutes of Health

Edward W. Holmes, MD
Executive Deputy Chairman, Clinical Translational Sciences,
A*Star Biomedical Research Council;
Lien Ying Chow Professor of Medicine,
NUS Yong Loo Lin School of Medicine;
Vice-Chancellor of Health Sciences Emeritus and Distinguished Professor,
University of California, San Diego

Peter K Honig, MD, MPH
Executive Vice President, Worldwide Regulatory Affairs and Product Safety
Merck & Co., Inc.

Richard A. Justman, MD
National Medical Director
UnitedHealth Group

Michael Katz, MD
Senior Vice President for Research and Global Programs
March of Dimes Foundation

David Korn, MD
Senior Vice President, Biomedical and Health Sciences Research
Association of American Medical Colleges

Ronald L. Krall, MD
Senior Vice President and Chief Medical Officer
GlaxoSmithKline

John R. Marler, MD
Associate Director for Clinical Trials
National Institute of Neurological Disorders and Stroke

Musa Mayer
Patient Advocate, Breast Cancer
AdvancedBC.org

Mark B. McClellan, MD, PhD
Director, Engelberg Center for Health Care Reform
Brookings Institution

Joshua J. Ofman, MD, MPH, MSHS
Vice President of Reimbursement & Payment Policy
Amgen, Inc.

Suzanne R. Pattee, JD
Vice President of Regulatory and Patient Affairs
Cystic Fibrosis Foundation

Joanne L. Rhoads, MD, MPH
National Institute of Allergy and Infectious Diseases (retired)

Janet Shoemaker
Director, Office of Public Affairs
American Society for Microbiology

Lana Skirboll, PhD
Director, Office of Science Policy
National Institutes of Health

Nancy Sung, PhD
Senior Program Officer
Burroughs Wellcome Fund

Jorge A. Tavel, MD
Deputy Director, Division of Clinical Research
National Institute of Allergy and Infectious Diseases

Janet Woodcock, MD
Director, Center for Drug Evaluation and Research
U.S. Food and Drug Administration

FORUM HOME